FDA Approves Nulojix for Kidney Transplant Patients
Links shared publicly online about this topic.
- 204total visits
FDA Approves Nulojix for Kidney Transplant Patients
View full resource at drugs.com
Tags: Kidney Health, Urinary System, Organ Transplantation, Organ Transplant Rejection Medication, Kidney Transplant, FDA, Belatacept, Transplantation
Most Recently Shared on June 20, 2011 at 11:13 pm By:
FDA Approves Nulojix for Kidney Transplant Patients - http://bit.ly/jzxd4w
Nulojix (belatacept) Approved To Prevent Acute Kidney Transplant Rejection
medicalnewstoday.com — “Nulojix (belatacept), a drug designed to be taken with other immunosuppressants, has been approved by the FDA (Food and Drug Administration) to prevent acute rejection of donated kidneys in transp” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 8:05 pm By:
MNT Drug Approvals Health News
Nulojix (belatacept) Approved To Prevent Acute Kidney Transplant Rejection http://mnt.to/3XhX #regulatory
FDA Approves Bristol-Myers Kidney Transplant Drug - FoxNews.com
foxnews.com — “U.S. health regulators approved on Wednesday a Bristol-Myers Squibb Co drug to prevent organ rejection in adult patients who have undergone a kidney transplant” View full resource at foxnews.com
Most Recently Shared on June 16, 2011 at 6:44 pm By:
Health,Fitness,Diet Health Business
FDA Approves Bristol-Myers Kidney Transplant Drug http://bit.ly/j0d4Aq
Anti-Rejection Drug Cleared for Use in Kidney Transplant Patients - Renal and Urology News
renalandurologynews.com — “The FDA has approved belatacept (Nulojix) for preventing acute rejection of transplanted kidneys in adults.” View full resource at renalandurologynews.com
Most Recently Shared on June 16, 2011 at 6:22 pm By:
Renal Urology News Nephrology, Urology, Medical Publisher, and Health News
Anti-Rejection Drug Cleared for Use in Kidney Transplant Patients: The FDA has approved belatacept (Nulojix) for... http://bit.ly/lO5Gvi
Nulojix Approved for Renal Transplant Patients - ONA
oncologynurseadvisor.com — “Bristol-Myers Squibb announced that the FDA has approved Nulojix (belatacept), a selective T-cell costimulation blocker, in combination with other immunosuppressants to prevent acute organ rejection in adult patients who have had a kidney transplant.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 16, 2011 at 2:49 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Nulojix Approved for Renal Transplant Patients http://goo.gl/fb/SCvqh
Kidney Transplantation Drug Gets Approved by the FDA | ThirdAge
thirdage.com — “Kidney transplantation drug works with other immunosuppressants to prevent acute organ rejection in adult patients” View full resource at thirdage.com
Most Recently Shared on June 16, 2011 at 11:07 am By:
Kidney Transplantation Drug Gets Approved by the FDA http://bit.ly/iTweqh
FDA approves Bristol-Myers kidney transplant drug | Reuters
reuters.com — “NEW YORK (Reuters) - U.S. health regulators approved on Wednesday a Bristol-Myers Squibb Co drug to prevent organ rejection in adult patients who have undergone a kidney transplant.The Food and Drug” View full resource at reuters.com
Most Recently Shared on June 15, 2011 at 10:53 pm By:
FDA approves Bristol-Myers kidney transplant drug http://bit.ly/iM1MZW
FDA approves Bristol-Myers kidney transplant drug | Reuters
reuters.com — “NEW YORK (Reuters) - U.S. health regulators approved on Wednesday a Bristol-Myers Squibb Co drug to prevent organ rejection in adult patients who have undergone a kidney transplant.The Food and Drug” View full resource at reuters.com
Most Recently Shared on June 15, 2011 at 10:44 pm By:
FDA approves Bristol-Myers kidney transplant drug http://reut.rs/mIp1A4
FDA Approves Longer Valganciclovir CMV Prophylaxis for Kidney Transplant Patients - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved an extended prophylactic dosing interval for valganciclovir HCl tablets in adult kidney transplant patients at high risk for cytomegalovirus disease. Medscape Medical News (Source: Medscape Today Headlines)” View full resource at qualitypointtech.net
Most Recently Shared on August 11, 2010 at 10:57 pm By:
FDA Approves Longer Valganciclovir CMV Prophylaxis for Kidney Transplant Patients: The FDA has approved an extende... http://bit.ly/bfiHbK
MarketWatch.com
marketwatch.com — “MarketWatch.com” View full resource at marketwatch.com
Most Recently Shared on August 10, 2010 at 10:27 pm By:
The Kidney Group Physician Group and Nephrology
FDA approves longer use of Valcyte in kidney transplant patients at high risk of CMV infection.http://bit.ly/b1tdgx
Novartis Receives US FDA Approval For Zortress(R) (everolimus) To Prevent Organ Rejection In Adult Kidney Transplant Recipients
medicalnewstoday.com — “The US Food and Drug Administration (FDA) has approved Zortress® (everolimus) oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologi” View full resource at medicalnewstoday.com
Most Recently Shared on April 24, 2010 at 3:06 pm By:
MNT Pharma News Pharma and Health News
Novartis Receives US FDA Approval For Zortress(R) (everolimus) To Prevent Organ Rejection In Adult Kidney Transplant R... http://mnt.to/3BJd
Medical News: FDA Approves Kidney Cancer Drug for Transplant Use - in Transplantation, Kidney Transplantation from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved everolimus (Zortress) for use in preventing organ rejection in adult kidney transplant patients.” View full resource at medpagetoday.com
Most Recently Shared on April 24, 2010 at 1:29 pm By:
FDA Approves Kidney Cancer Drug for Transplant Use http://bit.ly/afpvao
Zortress approved for organ rejection prophylaxis - MPR
empr.com — “The FDA has approved Zortress (everolimus tablets, from Novartis) for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk.” View full resource at empr.com
Most Recently Shared on April 22, 2010 at 3:05 pm By:
MPR News: Zortress approved for organ rejection prophylaxis: The FDA has approved Zortress (everolimus tablets, fr... http://bit.ly/cYieH6
Bristol-Myers Squibb's Belatacept for Transplants Wins Support - WSJ.com
online.wsj.com — “A U.S. federal advisory panel recommended approval of the drug for use in patients undergoing kidney transplants.” View full resource at online.wsj.com
Most Recently Shared on March 3, 2010 at 4:28 am By:
FDA advisory panel recommends approval of belatacept for kidney transplants. http://bit.ly/bWueDL
FDA panel backs Bristol transplant drug | Reuters
reuters.com — “WASHINGTON (Reuters) - Bristol-Myers Squibb Co's experimental kidney transplant drug belatacept should be approved to give doctors and patients more treatment choices, but long-term data and a stringent” View full resource at reuters.com
Most Recently Shared on March 2, 2010 at 12:15 am By:
FDA panel backs Bristol transplant drug: WASHINGTON (Reuters) - Bristol-Myers Squibb Co's experimenta... http://bit.ly/a4Hiap #health #news
Advertisement
